Glycomine

0 followers

‌

Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist.

Industries

Biotechnology

Headquarters

San Carlos, United States

Employees

11-50

Links

Org chart

Steven Axon

Director & CEO

Steven Axon

Collapse

Hicham Alaoui

Chief Scientific Officer

Geoffrey Hird

Chief Technology Officer

Peter McWilliams

Chief Business Officer

Kerryn Mccluskie

VP, Non-clinical Development

Lisa Koch-Hulle

Acting VP, Regulatory Affairs

Drew Folk

Sr. Director Of Product Development

Emily Tess

Chief of Staff, Director of Corporate Development & Strategy

Kevin Herlihy

Sr. Director Manufacturing Science And Technology

Colette Muenzen

Senior Legal Consultant

Rose Marino

Chief Medical Officer

Teams

+10

Directors

13 members

Leadership Team

3 members

Clinical and Regulatory

4 members

Similar companies

Biogen

114 followers

Exact Sciences

15 followers

Grassroots Analytics

54 followers

Sowell Management

42 followers

Ethos Support

14 followers

Blavity

5 followers

Shyft Group

3 followers

Artiva Biotherapeutics

1 follower

Apprenti

3 followers

UC Health

2 followers

Preservation of Affordable Housing, Inc.